{"filing":{"accession_number":"0001193125-26-281171","cik":"0001226616","ticker":"MNOV","company_name":"MEDICINOVA INC","form":"8-K","filing_date":"2026-06-24","report_date":null,"primary_document":"mnov-20260623.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1226616/000119312526281171/mnov-20260623.htm"},"events":[{"id":13559,"run_id":12048,"accession_number":"0001193125-26-281171","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a classic Item 5.07 disclosure reporting the results of MediciNova's 2026 annual meeting of stockholders held on June 23, 2026. The filing presents voting results for four proposals: election of two Class I directors (Hikedi Nagao and Nicole Lemerond), ratification of BDO USA as auditor, approval of an amendment to increase authorized shares (which failed to pass), and approval of adjournment. The material outcome is the failure of the share authorization increase proposal, which did not receive majority support from outstanding shares.","company_name":"MEDICINOVA INC","ticker":"MNOV","filing_date":"2026-06-24","form":"8-K","submitted_at":null,"items":[{"id":10730,"accession_number":"0001193125-26-281171","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of MediciNova's 2026 annual meeting of stockholders held on June 23, 2026. The filing presents voting results for four proposals: election of two Class I directors (Hikedi Nagao and Nicole Lemerond), ratification of BDO USA as auditor, approval of an amendment to increase authorized shares (which failed to pass), and approval of adjournment. The material outcome is the failure of the share authorization increase proposal, which did not receive majority support from outstanding shares.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:40:20.410109+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10730,"accession_number":"0001193125-26-281171","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of MediciNova's 2026 annual meeting of stockholders held on June 23, 2026. The filing presents voting results for four proposals: election of two Class I directors (Hikedi Nagao and Nicole Lemerond), ratification of BDO USA as auditor, approval of an amendment to increase authorized shares (which failed to pass), and approval of adjournment. The material outcome is the failure of the share authorization increase proposal, which did not receive majority support from outstanding shares.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T20:40:20.410109+00:00","company_name":"MEDICINOVA INC","ticker":"MNOV","filing_date":"2026-06-24"}]}